Related Experiment Video
Updated: May 18, 2026
11:02
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
Roman K Thomas1, Elizabeth Nickerson, Jan F Simons
1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA.
Nature Medicine
|June 27, 2006
Summary
Microreactor-based pyrosequencing improves DNA sequencing sensitivity for rare cancer variations. This advanced technique enhances molecular diagnosis and patient selection for targeted cancer therapies.
Area of Science:
- Oncology
- Genetics
- Biotechnology
Background:
- Conventional DNA sequencing of tumor biopsies faces limitations in sensitivity due to stromal contamination and intra-tumor genetic heterogeneity.
- Accurate detection of rare cancer-associated sequence variations is crucial for effective molecular diagnosis and personalized treatment strategies.
Purpose of the Study:
- To introduce and validate microreactor-based pyrosequencing as a method to overcome the limitations of conventional DNA sequencing in heterogeneous cancer specimens.
- To demonstrate the capability of this technology in detecting rare genetic alterations for improved cancer diagnostics.
Main Methods:
- Utilized microreactor technology for independent and parallel sampling of multiple DNA fragments from a single source.
- Employed pyrosequencing for high-throughput, accurate detection of DNA sequence variations.
- Applied the method to analyze heterogeneous cancer specimens.
Main Results:
- Microreactor-based pyrosequencing demonstrated enhanced sensitivity in detecting rare cancer-associated sequence variations compared to conventional methods.
- The technology effectively addressed challenges posed by stromal contamination and intra-tumor genetic heterogeneity.
- Successful identification of low-frequency genetic alterations was achieved.
Conclusions:
- Microreactor-based pyrosequencing offers a significant advancement for the molecular diagnosis of heterogeneous cancer.
- This technology facilitates more accurate patient stratification for targeted cancer therapies.
- The method holds promise for improving outcomes in precision oncology.
